Treatment of IgM antibody associated polyneuropathies using rituximab

Objectives: Polyneuropathies with associated serum IgM antibodies are often difficult to treat. Rituximab is a monoclonal antibody directed against the B cell surface membrane marker CD20. Rituximab eliminates B cells from the circulation, and, over time, could reduce cells producing autoantibodies....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pestronk, A, Florence, J, Miller, T, Choksi, R, Al-Lozi, M, Levine, T
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2003
Teme:
Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1738397/
https://ncbi.nlm.nih.gov/pubmed/12640069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.74.4.485
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki